Şener, GökselTerali, KeremOzbeyli, DilekYigit-Hanoglu, DuyguBaser, Kemal Husnu CanSener, GokselAykac, AsliEczacılık Meslek Bilimleri Bölümü2025-01-112025-01-11202412162-327910.1002/brb3.35072-s2.0-85191724936https://doi.org/10.1002/brb3.3507https://hdl.handle.net/20.500.14627/216Yigit Hanoglu, Duygu/0000-0003-1345-4768; Terali, Kerem/0000-0002-9964-6383Introduction: Alzheimer's disease (AD) is a neurodegenerative condition characterized by gradual loss of cognitive abilities (dementia) and is a major public health problem. Here, we aimed at investigating the effects of Rosa damascena essential oil (RDEO) on learning and memory functions in a rat model of amnesia induced by scopolamine, as well as on changes in acetylcholinesterase (AChE) activity, M-1 muscarinic acetylcholine receptor (mAChR) expression, and brain-derived neurotrophic factor (BDNF) levels in the extracted brain tissues. Methods: The control, amnesia (scopolamine, 1 mg/kg/i.p.) and treatment (RDEO, 100 mu L/kg/p.o. or galantamine, 1.5 mg/kg/i.p.) groups were subjected to Morris water maze and new object recognition tests. AChE activity was assayed by ELISA, and M-1 mAChR and BDNF concentration changes were determined by western blotting. Also, using computational tools, human M-1 mAChR was modeled in an active conformation, and the major components of RDEO were docked onto this receptor. Results: According to our behavioral tests, RDEO was able to mitigate the learning and memory impairments caused by scopolamine in vivo. Our in vitro assays showed that the observed positive effects correlated well with a decrease in AChE activity and an increase in M-1 mAChR and BDNF levels in amnestic rat brains. We also demonstrated in an in silico setting that the major components of RDEO, specifically -citronellol, geraniol, and nerol, could be accommodated favorably within the allosteric binding pocket of active-state human M-1 mAChR and anchored here chiefly by hydrogen-bonding and alkyl-pi interactions. Conclusion: Our findings offer a solid experimental foundation for future RDEO-based medicinal product development for patients suffering from AD.eninfo:eu-repo/semantics/openAccessAlzheimer'S DiseaseCholinergic SystemCognitive FunctionsScopolamine-Induced AmnesiaArticleQ2Q2145WOS:00121100240000138688895